| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| pembrolizumab for cancer patients | 1.16 | 0.4 | 8185 | 72 | 33 |
| pembrolizumab | 1.17 | 0.5 | 4146 | 28 | 13 |
| for | 0.3 | 0.6 | 9936 | 28 | 3 |
| cancer | 1.74 | 0.2 | 2738 | 11 | 6 |
| patients | 0.8 | 0.2 | 8801 | 37 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| pembrolizumab for cancer patients | 0.48 | 1 | 9448 | 5 |
| pembrolizumab for breast cancer | 0.15 | 0.5 | 8804 | 3 |
| pembrolizumab for colon cancer | 1.35 | 0.5 | 1047 | 19 |
| pembrolizumab for pancreatic cancer | 0.51 | 0.1 | 6737 | 30 |
| pembrolizumab in lung cancer | 0.53 | 0.1 | 1725 | 47 |
| pembrolizumab chemotherapy lung cancer | 1.46 | 0.5 | 1331 | 96 |
| pembrolizumab for bladder cancer | 1.93 | 0.1 | 2007 | 60 |
| pembrolizumab for cervical cancer | 1.62 | 0.5 | 6207 | 83 |
| pembrolizumab for prostate cancer | 1.66 | 0.3 | 1942 | 17 |
| pembrolizumab for urothelial cancer | 1.85 | 0.2 | 3925 | 66 |
| pembrolizumab is it chemotherapy | 0.61 | 0.5 | 7446 | 55 |
| pembrolizumab lung cancer fda | 0.24 | 0.6 | 1455 | 2 |
| breast cancer now pembrolizumab | 0.03 | 0.3 | 3057 | 47 |
| pembrolizumab in colorectal cancer | 1.09 | 0.5 | 1807 | 62 |
| pembrolizumab is a chemo drug | 0.23 | 1 | 3635 | 35 |
| is pembrolizumab a chemotherapy drug | 1.96 | 0.4 | 9139 | 100 |
| pembrolizumab chemotherapy or immunotherapy | 0.9 | 0.1 | 310 | 66 |
| pembrolizumab is chemo or not | 1.18 | 0.6 | 1217 | 74 |
